{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:09:31Z","timestamp":1789992571065,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,21]]},"DOI":"10.7759\/cureus.116624","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:25:56Z","timestamp":1789989956000},"source":"Crossref","is-referenced-by-count":0,"title":["Spontaneous Perigastric Hematoma and Hemoperitoneum Associated With Rivaroxaban Therapy: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Bouya","family":"Rachad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Mbina Nzienghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoufal","family":"Chouaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Belkouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel MR","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al.. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011, 365:883-91. 10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel J","year":"2021","unstructured":"Steffel J, Collins R, Antz M, et al.. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021, 23:1612-76. 10.1093\/europace\/euab065","journal-title":"Europace"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092984","article-title":"A review of the incidence diagnosis and treatment of spontaneous hemorrhage in patients treated with direct oral anticoagulants","volume":"9","author":"Gunasekaran K","year":"2020","unstructured":"Gunasekaran K, Rajasurya V, Devasahayam J, Singh Rahi M, Chandran A, Elango K, Talari G. A review of the incidence diagnosis and treatment of spontaneous hemorrhage in patients treated with direct oral anticoagulants. J Clin Med. 2020, 9:2984. 10.3390\/jcm9092984","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt DM","year":"2018","unstructured":"Witt DM, Nieuwlaat R, Clark NP, et al.. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018, 2:3257-91. 10.1182\/bloodadvances.2018024893","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2017.11.001","article-title":"Warfarin resumption following anticoagulant-associated intracranial hemorrhage: a systematic review and meta-analysis","volume":"160","author":"Chai-Adisaksopha C","year":"2017","unstructured":"Chai-Adisaksopha C, Iorio A, Hillis C, Siegal D, Witt DM, Schulman S, Crowther M. Warfarin resumption following anticoagulant-associated intracranial hemorrhage: a systematic review and meta-analysis. Thromb Res. 2017, 160:97-104. 10.1016\/j.thromres.2017.11.001","journal-title":"Thromb Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff CT","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al.. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014, 383:955-62. 10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"Mueck W","year":"2014","unstructured":"Mueck W, Stampfuss J, Kubitza D, Becka M. Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban. Clin Pharmacokinet. 2014, 53:1-16. 10.1007\/s40262-013-0100-7","journal-title":"Clin Pharmacokinet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)91639-0","article-title":"Assessment of coma and impaired consciousness: a practical scale","volume":"304","author":"Teasdale G","year":"1974","unstructured":"Teasdale G, Jennett B. Assessment of coma and impaired consciousness: a practical scale. Lancet. 1974, 304:P81-4. 10.1016\/S0140-6736(74)91639-0","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2014.01.049","article-title":"Spontaneus splenic rupture in a patient treated with rivaroxaban","volume":"32","author":"Gonzva J","year":"2014","unstructured":"Gonzva J, Patricelli R, Lignac D. Spontaneus splenic rupture in a patient treated with rivaroxaban. Am J Emerg Med. 2014, 32:950.e3. 10.1016\/j.ajem.2014.01.049","journal-title":"Am J Emerg Med"},{"key":"ref11","article-title":"Hemorrhagic shock from spontaneous splenic rupture requiring open splenectomy in a patient taking rivaroxaban","volume":"82","author":"Amin A","year":"2016","unstructured":"Amin A, Safaya A, Ronny F, Islam H, Bhuta K, Rajdeo H. Hemorrhagic shock from spontaneous splenic rupture requiring open splenectomy in a patient taking rivaroxaban. Am Surg. 2016, 82:E54-5.","journal-title":"Am Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223237","article-title":"Spontaneous splenic rupture due to rivaroxaban","volume":"2018","author":"Nagaraja V","year":"2018","unstructured":"Nagaraja V, Cranney G, Kushwaha V. Spontaneous splenic rupture due to rivaroxaban. BMJ Case Rep. 2018, 2018:223237. 10.1136\/bcr-2017-223237","journal-title":"BMJ Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-226870","article-title":"Acute cholecystitis and gallbladder perforation leading to massive haemoperitoneum in a patient taking rivaroxaban","volume":"2018","author":"Kwok A","year":"2018","unstructured":"Kwok A, Chern TY, Winn R. Acute cholecystitis and gallbladder perforation leading to massive haemoperitoneum in a patient taking rivaroxaban. BMJ Case Rep. 2018, 2018:226870. 10.1136\/bcr-2018-226870","journal-title":"BMJ Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6462","article-title":"Atraumatic splenic rupture in a patient treated with rivaroxaban: a case report and a narrative review","volume":"10","author":"Labaki ML","year":"2022","unstructured":"Labaki ML, De Kock M. Atraumatic splenic rupture in a patient treated with rivaroxaban: a case report and a narrative review. Clin Case Rep. 2022, 10:e6462. 10.1002\/ccr3.6462","journal-title":"Clin Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-025-00617-z","article-title":"Successful embolisation of a spontaneous diffuse subcapsular liver bleeding in a patient receiving rivaroxaban","volume":"8","author":"Waters DK","year":"2025","unstructured":"Waters DK, Alderson J, Mulholland D. Successful embolisation of a spontaneous diffuse subcapsular liver bleeding in a patient receiving rivaroxaban. CVIR Endovasc. 2025, 8:116. 10.1186\/s42155-025-00617-z","journal-title":"CVIR Endovasc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.053","article-title":"2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"76","author":"Tomaselli GF","year":"2020","unstructured":"Tomaselli GF, Mahaffey KW, Cuker A, et al.. 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020, 76:594-622. 10.1016\/j.jacc.2020.04.053","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.148.1.6856833","article-title":"Hemoperitoneum studied by computed tomography","volume":"148","author":"Federle MP","year":"1983","unstructured":"Federle MP, Jeffrey RB Jr. Hemoperitoneum studied by computed tomography. Radiology. 1983, 148:187-92. 10.1148\/radiology.148.1.6856833","journal-title":"Radiology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.10.044","article-title":"Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation","volume":"113","author":"Qureshi W","year":"2014","unstructured":"Qureshi W, Mittal C, Patsias I, et al.. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol. 2014, 113:662-8. 10.1016\/j.amjcard.2013.10.044","journal-title":"Am J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.03.053","article-title":"Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: a systematic review and meta-analysis","volume":"261","author":"Proietti M","year":"2018","unstructured":"Proietti M, Romiti GF, Romanazzi I, Farcomeni A, Staerk L, Nielsen PB, Lip GY. Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: a systematic review and meta-analysis. Int J Cardiol. 2018, 261:84-91. 10.1016\/j.ijcard.2018.03.053","journal-title":"Int J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523501-spontaneous-perigastric-hematoma-and-hemoperitoneum-associated-with-rivaroxaban-therapy-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:25:56Z","timestamp":1789989956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523501-spontaneous-perigastric-hematoma-and-hemoperitoneum-associated-with-rivaroxaban-therapy-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.116624","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}